Integral Health Asset Management’s Boston Scientific BSX Stock Holding History

Integral Health Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.4M	Buy	900,000 +350,000	+64%	+$19M	1.52%	18
2026 Q1	$34.5M	Buy	550,000 +325,000	+144%	+$26M	1.65%	18
2025 Q4	$21.5M	Sell	225,000 -75,000	-25%	-$7.35M	1.07%	31
2025 Q3	$29.3M	Sell	300,000 -250,000	-45%	-$25.9M	1.98%	9
2025 Q2	$59.1M	Sell	550,000 -100,000	-15%	-$10.1M	5.41%	2
2025 Q1	$65.6M	Buy	650,000 +100,000	+18%	+$10.1M	6.98%	2
2024 Q4	$49.1M	Hold	550,000	–	–	4.19%	3
2024 Q3	$46.1M	Sell	550,000 -100,000	-15%	-$7.88M	5.19%	3
2024 Q2	$50.1M	Buy	650,000 +50,000	+8%	+$3.66M	4.76%	4
2024 Q1	$41.1M	Buy	600,000 +225,000	+60%	+$14.5M	3.81%	2
2023 Q4	$21.7M	Sell	375,000 -175,000	-32%	-$9.34M	2.95%	7
2023 Q3	$29M	Buy	550,000 +84,000	+18%	+$4.41M	4.02%	3
2023 Q2	$25.2M	Buy	466,000 +314,000	+207%	+$16.4M	3.12%	6
2023 Q1	$7.6M	Buy	+152,000	New	+$7.16M	1.53%	29
2022 Q4	–	Sell	-350,000	Closed	-$13.6M	–	70
2022 Q3	$13.6M	Buy	+350,000	New	+$14M	2.63%	12
2020 Q2	–	Sell	-125,000	Closed	-$4.08M	–	66
2020 Q1	$4.08M	Sell	125,000 -75,000	-38%	-$2.93M	1.8%	21
2019 Q4	$9.04M	Buy	+200,000	New	+$8.37M	3.52%	9

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Integral Health Asset Management's BSX Position: Q2 2026 in Review

Integral Health Asset Management increased its Boston Scientific (BSX) stake by 64% in Q2 2026, buying an estimated $19M and bringing the position to 900,000 shares worth $38.4M. The position accounts for 1.52% of the portfolio, ranked #18.

Integral Health Asset Management first reported a position in BSX in Q4 2019 and has held it in 17 quarters since. The position peaked at $65.6M in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Integral Health Asset Management held 900,000 shares of Boston Scientific worth $38.4M as of Q2 2026.
Integral Health Asset Management bought 350,000 Boston Scientific shares in Q2 2026, an estimated $19M.
Boston Scientific made up 1.52% of Integral Health Asset Management's portfolio in Q2 2026, its #18 holding.
Integral Health Asset Management first reported a position in Boston Scientific in Q4 2019 and has held it in 17 quarters since.
Integral Health Asset Management's Boston Scientific position peaked at $65.6M in Q1 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.